In line with this hypothesis, IFNγ is required for successful tumor rejection by dual blockade of TGFβ and PD-L1, and knocking out IFNγ receptor in tumor cells leads to decreased complete response to dual PD-L1 TGFβ blockade. The gene discussed is TGFB1; the disease is neoplasm.